Market Research Logo

Osiris Therapeutics Inc (OSIR) - Financial and Strategic SWOT Analysis Review

Osiris Therapeutics Inc (OSIR) - Financial and Strategic SWOT Analysis Review

Osiris Therapeutics Inc (OSIR) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Osiris Therapeutics Inc (Osiris) is a regenerative medicine company. It researches, develops and markets regenerative medicine products. The company developed the world's first approved stem cell drug. It offers products in wound care, orthopedics, and sports medicine market. Osiris develops products based on BioSmart, a proprietary process for tissue and cell preservation that maintains integrity of the biological materials. Osiris, Grafix, Stravix and Cartiform are trademarks of Osiris. The company continues to advance its research and development (R&D) in biotechnology by focusing on innovation in regenerative medicine including stem cell research, bioengineering and viable tissue based products. Osiris is headquartered in Columbia, Maryland, the US.

Osiris Therapeutics Inc Key Recent Developments

Nov 07,2018: Osiris Therapeutics reports third quarter 2018 results
Oct 03,2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues is an alternative to cryopreservation
Oct 03,2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues is an alternative to cryopreservation
Oct 02,2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues
Jun 04,2018: Osiris Announces Implementation of Prestige Lyotechnology Preservation Method Allowing Ambient Storage of Living Tissues

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Osiris Therapeutics Inc - Key Facts
Osiris Therapeutics Inc - Key Employees
Osiris Therapeutics Inc - Key Employee Biographies
Osiris Therapeutics Inc - Major Products and Services
Osiris Therapeutics Inc - History
Osiris Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Osiris Therapeutics Inc - Business Description
Osiris Therapeutics Inc - Corporate Strategy
Osiris Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Osiris Therapeutics Inc - Strengths
Osiris Therapeutics Inc - Weaknesses
Osiris Therapeutics Inc - Opportunities
Osiris Therapeutics Inc - Threats
Osiris Therapeutics Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s, Lifesciences Financial Deals and Alliances
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Osiris Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 07, 2018: Osiris Therapeutics reports third quarter 2018 results
Oct 03, 2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues is an alternative to cryopreservation
Oct 03, 2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues is an alternative to cryopreservation
Oct 02, 2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues
Jun 04, 2018: Osiris Announces Implementation of Prestige Lyotechnology Preservation Method Allowing Ambient Storage of Living Tissues
Feb 06, 2018: Osiris Appoints Willi Miesch to its Board of Directors, Change in CEO
Oct 23, 2017: Osiris Announces a Peer-Reviewed Publication of a Scientific Study Reporting Antimicrobial Properties of Human Cryopreserved Viable Amniotic Membrane
Oct 19, 2017: Osiris Therapeutics to Present 10 Advanced Clinical and Scientific Abstracts, Including an Exclusive Oral Presentation on its New Ambient Viable Tissue Preservation Technology
Jun 26, 2017: Osiris Appoints Linda Palczuk to serve as its President & CEO
May 31, 2017: Osiris Appoints David White to its Board of Directors
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Osiris Therapeutics Inc, Key Facts
Osiris Therapeutics Inc, Key Employees
Osiris Therapeutics Inc, Key Employee Biographies
Osiris Therapeutics Inc, Major Products and Services
Osiris Therapeutics Inc, History
Osiris Therapeutics Inc, Subsidiaries
Osiris Therapeutics Inc, Key Competitors
Osiris Therapeutics Inc, Ratios based on current share price
Osiris Therapeutics Inc, Annual Ratios
Osiris Therapeutics Inc, Annual Ratios (Cont...1)
Osiris Therapeutics Inc, Interim Ratios
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Osiris Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Osiris Therapeutics Inc, Performance Chart (2013 - 2017)
Osiris Therapeutics Inc, Ratio Charts
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report